Programmed cell death ligand-1 (PD-L1) is commonly overexpressed in glioma cells and affects PI3K/AKT signaling pathways [10], which alternatively remodel the production of BCAAs [9]. This evidence concerns the gene AKT1 and central nervous system cancer.